The Peptic Ulcer Drugs Market To Look Through Real-Time Analytics Through Digitization
Surge in the
consumption of NSAIDs due to growing prevalence of inflammatory diseases is the
major factor driving the growth of the global peptic ulcer drugs market. Other
trends driving growth include increasing adoption of peptic ulcer drugs over
surgery, changes in disease management, prevalence of stress ulcers due to
higher smoking rates, availability of affordable therapy due to improvements in
the service sector, and increasing awareness toward disease management through
government campaigns. However, chronic side-effects associated with the
long-term use of peptic ulcer drugs is a factor hampering the growth of the
global peptic ulcer drugs market to some extent.
As per PMR
analysis, the global peptic ulcer drugs market is set for steady growth over
the next ten years, to be valued at US$ 47.7 Bn by 2030-end.
How About Looking Through The Sample Of Peptic Ulcer Drugs Market
Report? https://www.persistencemarketresearch.com/samples/3704
Companies covered in Peptic Ulcer Drugs Market Report
·
Pfizer Inc.
·
Abbvie Inc.
·
GlaxoSmithKline plc.
·
AstraZeneca plc
·
Boehringer Ingelheim GmbH
·
Daewoong Pharmaceutical Co., Ltd.
·
Takeda Pharmaceutical
·
Eisai Co. Ltd.
·
Cadila Healthcare Ltd.
·
Yuhan Corporation
How About Step-By-Step Insights To
Peptic Ulcer Drugs Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.com/methodology/3704
Key Takeaways from Peptic Ulcer Drugs Market Study
·
By product, the proton pump inhibitors segment was the largest revenue generating
segment in the historical years. However, revenue from the
potassium-competitive acid blockers segment is expected to expand rapidly,
owing to the introduction of new P-CAB drugs in the market.
·
Based on indication, the gastric ulcers segment is anticipated to expand
at the highest CAGR of 3% over the forecast period.
·
On the basis of distribution channel, the hospital pharmacies segment
led the global peptic ulcer drugs market, and is expected to remain the leading
segment ahead too. Increasing hospitalization rates due to ulcer complications
are expected to be the primary factor fuelling revenue growth of the segment
over the forecast period.
·
North America holds the largest share in the global peptic ulcer drugs
market, followed by Europe and East Asia.
·
Due to the worldwide COVID-19 outbreak, physician and
hospital visits for non-essential treatment have reduced considerably, putting
breaks on the progress of the peptic ulcer drugs market space.
“Increasing NSAID consumption is the major boosting factor for the
growth of the global peptic ulcer drugs market,” says a PMR analyst.
Want To Keep A Tab On The Latest Findings In The Peptic Ulcer Drugs
Market? Purchase Our Peptic Ulcer Drugs Market Report Now! https://www.persistencemarketresearch.com/checkout/3704
Peptic Ulcer Drugs Market: Competition Analysis
Key players
operating in the global peptic ulcer drugs market are Daewoong Pharmaceutical
Co. Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Abbott
Laboratories, AstraZeneca Plc., Cadila Healthcare Ltd., Boehringer Ingelheim
GmbH, Eisai Co. Ltd., Yuhan Corporation, and GlaxoSmithKline Pharmaceuticals
Ltd. These companies are primarily focusing on strategies such as co-promotions
and co-marketing of their brands to penetrate the fastest-growing emerging
markets across the world.
What Else is in the Report?
Persistence Market
Research offers a unique perspective and actionable insights on the peptic
ulcer drugs market in its latest study, presenting historical demand assessment
of 2015–2019 and projections for 2020–2030.
Research of this report has been done based segmentation into product,
indication, and distribution channel, across seven key regions of the world.
About Us :-
Persistence Market
Research is here to provide companies a one-stop solution with regards to
bettering customer experience. It does engage in gathering appropriate feedback
after getting through personalized customer interactions for adding value to customers’
experience by acting as the “missing” link between “customer relationships” and
“business outcomes’. The best possible returns are assured therein.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Comments
Post a Comment